Actively Recruiting
Online Prehabilitation for Patients Awaiting Liver Transplantation
Led by University of Alberta · Updated on 2026-04-08
177
Participants Needed
6
Research Sites
163 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Physical frailty is common in patients awaiting liver transplantation and has been associated with poor health outcomes. There is promising data from small studies showing that behavioural, nutrition, exercise therapy (prehabilitation) improves physical function in patients while they are waiting for a liver transplant. The proposed trial will assess if a 12-week online prehabilitation program improves physical function in patients listed for liver transplantation. Over 4 years, 177 patients will be recruited from 6 transplant centres across Canada and will be randomized to receive either the online prehabilitation program or usual care. The primary outcome of physical function will be evaluated using the FTSST at baseline and 12 weeks (or last timepoint before transplant) assessed virtually or in-person. Secondary outcomes include liver specific physical frailty, aerobic fitness, health-related quality of life (QoL), participant experience and acceptability. Exploratory outcomes include other virtual and in-person physical function measures, covert hepatic encephalopathy (CHE), sarcopenia, malnutrition, adherence, behaviour factors, clinical and post-transplant outcomes. Results will be compared between the intervention and usual care groups.
CONDITIONS
Official Title
Online Prehabilitation for Patients Awaiting Liver Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older with cirrhosis confirmed by medical tests
- Referred for liver transplant or already listed for transplantation
- Assessed as pre-frail or frail using the liver frailty index or TeLeFI
- Able to communicate in English or French
- Own an internet-connected device
You will not qualify if you...
- Listed for living donor transplant with expected wait time under 12 weeks or MELD-Na score above 26
- Considered robust on frailty testing
- Unable to provide informed consent
- Have a clinical condition or environment that prevents safe participation
- Life expectancy less than six months or receiving compassionate care
- Recent variceal bleeding or untreated varices
- Transplant needed for cholangiocarcinoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Foothills Medical Centre
Calgary, Alberta, Canada, T2N 2T9
Actively Recruiting
2
Kaye Edmonton Clinic
Edmonton, Alberta, Canada, T6G1Z1
Actively Recruiting
3
Gordon and Leslie Diamond Health Care Centre
Vancouver, British Columbia, Canada, V5Z 1M9
Actively Recruiting
4
London Health Sciences Centre
London, Ontario, Canada, N6A 5W9
Actively Recruiting
5
Toronto General Hospital - Ajmera Transplant Centre
Toronto, Ontario, Canada, M5G 0A3
Actively Recruiting
6
McGill University Health Centre
Montreal, Quebec, Canada, H4A3J1
Actively Recruiting
Research Team
P
Puneeta Tandon
CONTACT
M
Margaret McNeely
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here